Supplier Research

GanedenBC30 Protects Against C. diff.

November 1, 2012

New research has been announced by Ganeden Biotech, Cleveland, OH, which indicated that their probiotic strain GanedenBC30 might aid in the prevention of C. difficile-induced infection (CDI). Recently published in the journal Gut Pathogens, the study demonstrated that Bacillus coagulans GBI-30, 6086 (GanedenBC30) prevents the recurrence of CDI in mice. Additionally, the study found that the mice given GanedenBC30 when re-infected with C.diff experienced more mild symptoms and recovered faster than those mice that were not given the probiotic. Dr. David Keller, vice president of scientific operations at Ganeden Biotech and one of the study’s authors explained, “Currently antibiotics are the primary weapon in the arsenal to fight C. diff. These findings show that the probiotic GanedenBC30 may provide an alternative.” 
For further information: http://www.gutpathogens.com/content/4/1/13/abstract

Related Health Conditions:

Related Market Segments:

blog comments powered by Disqus
  • Herbs & Botanicals Bounce Back

    Herbs & Botanicals Bounce Back

    Lisa Olivo, Associate Editor||July 1, 2016
    Industry rallies to cultivate quality with hopes of ensuring long-term market health.

  • Healthy Beverage Market Overflowing With Opportunities

    Healthy Beverage Market Overflowing With Opportunities

    Sean Moloughney, Editor||July 1, 2016
    Clean and simple formulas that incorporate vital nutrients will continue to gain market share.

  • Choosing The Right Analytical Lab

    Choosing The Right Analytical Lab

    Maged Sharaf, PhD, American Herbal Products Association ||July 1, 2016
    Here are some important questions to consider when determining which contract laboratory will meet your needs.